REPORT ON A CONFERENCE - POST-MARKETING DRUG SAFETY MONITORING

被引：1
|
作者：
CLARKNIEUWLAND, K [1 ]
DEHAEN, F [1 ]
TEIRLYNCK, O [1 ]
机构：
[1] CIBA GEIGY BELGIUM,DEPT MED,B-1720 GROOT BIJGAARDEN,BELGIUM
来源：
HEALTH POLICY | 1989年 / 11卷 / 03期
关键词：
D O I：
10.1016/0168-8510(89)90004-3
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：239 / 241
页数：3
相关论文
共 50 条
  • [1] Post-marketing drug safety in the era of genomic medicine
    Zavras, AI
    JOURNAL OF DENTAL RESEARCH, 2005, 84 (02) : 105 - 106
  • [2] Post-marketing drug safety sources: An evaluation of the FDA's drug safety communications
    Aldayel, Atheer
    Alghamdi, Maha
    Almutairi, Abdulaali
    Al-Harbi, Fawaz F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 302 - 302
  • [3] POST-MARKETING MONITORING OF DRUGS
    LEWIS, JA
    CHILVERS, C
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 (10) : 874 - 877
  • [4] Post-marketing studies - The work of the Drug Safety Research Unit
    Mackay, FJ
    DRUG SAFETY, 1998, 19 (05) : 343 - 353
  • [5] Quantification of unmeasured confounding in a post-marketing drug monitoring program
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Brodovicz, Kimberly G.
    Meyers, Andrea
    Bartels, Dorothee B.
    Barberio, Julie
    Liu, Jun
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 345 - 345
  • [6] Post-Marketing StudiesThe Work of the Drug Safety Research Unit
    Fiona Jean Mackay
    Drug Safety, 1998, 19 : 343 - 353
  • [7] Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies
    Khan, Zakir
    Karatas, Yusuf
    Akici, Ahmet
    Martins, Maria Auxiliadora Parreiras
    Ahmad, Nafees
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] POST-MARKETING DRUG SURVEILLANCE
    WALDEN, RJ
    PRICHARD, BNC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 191 - 192
  • [9] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [10] Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data
    Penedones, Ana
    Batel-Marques, Francisco
    PHARMACOTHERAPY, 2014, 34 (06): : E86 - E86
12345